Literature DB >> 19057457

Mortality and associated factors after initiation of pediatric antiretroviral treatment in the Democratic Republic of the Congo.

Steven F J Callens1, Nicole Shabani, Jean Lusiama, Patricia Lelo, Faustin Kitetele, Robert Colebunders, Ziya Gizlice, Andrew Edmonds, Annelies Van Rie, Frieda Behets.   

Abstract

OBJECTIVE: We aimed to describe factors associated with mortality among children receiving antiretroviral treatment (ART) at a pediatric hospital in Kinshasa, Democratic Republic of the Congo.
RESULTS: Two hundred ninety-nine children, <18 years old, were followed for a median of 77 weeks (interquartile range: 61-103) post-ART initiation. Survival probability was 89.6% [95% confidence interval (CI): 85.5-92.6%] at 12 months; 24 of 31 deaths (77.4%) occurred within 2 months of ART initiation. Predictors of mortality in bivariate analysis were >/=2 opportunistic infections before ART initiation, severe immunosuppression as defined by age-specific CD4 count or percentage criteria, hemoglobin <9 g/dL, oral candidiasis, and severe malnutrition. In multivariate analysis, weight for age z-score [hazard ratio (HR): 0.39; 95% CI: 0.27-0.61; P < 0.001] and oral candidiasis (HR: 5.86; 95% CI: 2.34-14.65; P = 0.0002) were independent predictors of mortality. Suspected septic shock was the most common cause of death (n = 12/31, 38.7%).
CONCLUSIONS: Children receiving ART in this resource-poor setting were at the highest risk of dying in the first 2 months of ART, particularly when they presented with malnutrition or oral candidiasis. Optimal timing of ART initiation during nutritional rehabilitation should be determined. Promotion of early care seeking, strengthened health care, and prevention services are important to further improve outcome of pediatric ART in resource-poor settings.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19057457     DOI: 10.1097/INF.0b013e318184eeb9

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  19 in total

1.  Viral load predicts new world health organization stage 3 and 4 events in HIV-infected children receiving highly active antiretroviral therapy, independent of CD4 T lymphocyte value.

Authors:  Ricardo Oliveira; Margot Krauss; Suzanne Essama-Bibi; Cristina Hofer; D Robert Harris; Adriana Tiraboschi; Ricardo de Souza; Heloisa Marques; Regina Succi; Thalita Abreu; Marinella Della Negra; Rohan Hazra; Lynne M Mofenson; George K Siberry
Journal:  Clin Infect Dis       Date:  2010-11-01       Impact factor: 9.079

2.  Predictors for mortality and loss to follow-up among children receiving anti-retroviral therapy in Lilongwe, Malawi.

Authors:  Bradley C Fetzer; Mina C Hosseinipour; Portia Kamthuzi; Lisa Hyde; Brian Bramson; Kebba Jobarteh; Kristine Torjesen; William C Miller; Irving Hoffman; Peter Kazembe; Charles Mwansambo
Journal:  Trop Med Int Health       Date:  2009-06-28       Impact factor: 2.622

3.  Immunologic risk factors for early mortality after starting antiretroviral therapy in HIV-infected Zambian children.

Authors:  Kaitlin Rainwater-Lovett; Hope C Nkamba; Mwangelwa Mubiana-Mbewe; Carolyn Bolton Moore; William J Moss
Journal:  AIDS Res Hum Retroviruses       Date:  2012-10-31       Impact factor: 2.205

Review 4.  Noncommunicable diseases in HIV infection in low- and middle-income countries: gastrointestinal, hepatic, and nutritional aspects.

Authors:  Paul Kelly; Haroon Saloojee; Jennifer Y Chen; Raymond T Chung
Journal:  J Acquir Immune Defic Syndr       Date:  2014-09-01       Impact factor: 3.731

5.  High completion of isoniazid preventive therapy among HIV-infected children and adults in Kinshasa, Democratic Republic of Congo.

Authors:  Marcel Yotebieng; Andrew Edmonds; Patricia Lelo; Landry Kipula Wenzi; Papy Tshishikani Ndjibu; Jean Lusiama; Jean Pierre Kabuayi; Frieda Behets
Journal:  AIDS       Date:  2015-09-24       Impact factor: 4.177

6.  Barriers to and facilitators of adherence to pediatric antiretroviral therapy in a sub-Saharan setting: insights from a qualitative study.

Authors:  Bradley C Fetzer; Bavon Mupenda; Jean Lusiama; Faustin Kitetele; Carol Golin; Frieda Behets
Journal:  AIDS Patient Care STDS       Date:  2011-08-08       Impact factor: 5.078

7.  Survival benefit of early infant antiretroviral therapy is compromised when diagnosis is delayed.

Authors:  Dalton Wamalwa; Sarah Benki-Nugent; Agnes Langat; Ken Tapia; Evelyn Ngugi; Jennifer A Slyker; Barbra A Richardson; Grace C John-Stewart
Journal:  Pediatr Infect Dis J       Date:  2012-07       Impact factor: 2.129

8.  Challenges in infant and young child nutrition in the context of HIV.

Authors:  Tin Tin Sint; Ronnie Lovich; Wendy Hammond; Maria Kim; Sara Melillo; Lydia Lu; Pamela Ching; Jennifer Marcy; Nigel Rollins; Emilia H Koumans; Amie N Heap; Margaret Brewinski-Isaacs
Journal:  AIDS       Date:  2013-11       Impact factor: 4.177

Review 9.  Understanding the contribution of common childhood illnesses and opportunistic infections to morbidity and mortality in children living with HIV in resource-limited settings.

Authors:  Surbhi Modi; Alex Chiu; Bernadette Ng'eno; Scott E Kellerman; Nandita Sugandhi; Lulu Muhe
Journal:  AIDS       Date:  2013-11       Impact factor: 4.177

10.  Mortality and treatment outcomes of China's National Pediatric antiretroviral therapy program.

Authors:  Yan Zhao; Chunming Li; Xin Sun; Weiwei Mu; Jennifer M McGoogan; Yun He; Yuewu Cheng; Zhirong Tang; Huiqin Li; Mingjian Ni; Ye Ma; Ray Y Chen; Zhongfu Liu; Fujie Zhang
Journal:  Clin Infect Dis       Date:  2012-11-21       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.